Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPROCHS: Activated protein C and low-dose corticosteroids in adult septic shock
2007-004485-40Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of drotrecogin alfa, hydrocortisone and fludrocortisone in septic shock (4 arms), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2007; status: completed.
02
Drugs
drotrecogin alfahydrocortisonefludrocortisone
03
Conditions
septic shock
Beyond the preview
Go deeper on 2007-004485-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004485-40.